Stocktoria

Travere Therapeutics, Inc. TVTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2003-07-23

Travere Therapeutics, Inc. statistics & valuation

P / S11.2×
P / B47.7×
Net margin-5.2%
Return on capital-14.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-35.90% -38.60% -62.50% -83.50% -85.40% -136.60% -254.40% -76.70% -137.90% -5.20% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-43.60% -34.70% -48.70% -78.30% -88.80% -151.30% -292.20% -267.20% -138.90% -12.80% 2016201720182019202020212022202320242025
Return on equity (%)
-15.60% -20.40% -32.30% -66.20% -80.20% -59.60% -649.90% -55.50% -544.30% -22.20% 2016201720182019202020212022202320242025
Shares outstanding
38.3M 39.4M 41.4M 43.1M 52.2M 62.5M 64.3M 75.4M 87.5M 90.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-9.10% -11.50% -14.50% -24.20% -27.90% -23.20% -41.40% -14.10% -54.10% -4.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-3.60% 4.20% -15.60% -33.30% -25.00% -61.70% -238.50% -224.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.29 -$1.54 -$2.54 -$3.46 -$3.56 -$3.01 -$4.37 -$1.50 -$4.08 -$0.29 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-12.8%-138.9%-267.2%-292.2%-151.3%-88.8%-78.3%-48.7%-34.7%-43.6%
Net margin-5.2%-137.9%-76.7%-254.4%-136.6%-85.4%-83.5%-62.5%-38.6%-35.9%
FCF margin-224.5%-238.5%-61.7%-25.0%-33.3%-15.6%4.2%-3.6%
Return on assets-4.2%-54.1%-14.1%-41.4%-23.2%-27.9%-24.2%-14.5%-11.5%-9.1%
Return on equity-22.2%-544.3%-55.5%-649.9%-59.6%-80.2%-66.2%-32.3%-20.4%-15.6%
Current ratio2.742.083.473.424.704.434.504.743.803.99

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.